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Dear Editor,
In the April 2014 issue of the online-first article, Rossoni et al.
[1] reported that Candida albicans serotype B is more sensi-
tive to photodynamic treatment than serotype A.
As we know, significant variation among particular strains
within the same species in response to the photodynamic
treatment exists [2]. The differences can reach several logs
in survival of viable counts. We have previously shown that
taking into consideration the genetic background of microor-
ganisms, i.e., Staphylococcus aureus, within the same closely
related strains, assigned as a single epidemic clone, we can
identify strains that are highly resistant as well as highly
sensitive to photodynamic inactivation (PDI) [3]. Thus, just
having a sufficiently large database of strains, one can prop-
erly infer about the importance of a particular feature in
response to PDI. Unfortunately, as far as I am concerned,
study of Rossoni et al. failed to include other than single
reference strains ofC. albicans. On the basis of single isolates,
one must not drew any relevant conclusions.
Moreover, switching the sensitizer can totally reverse the
observed response to photodynamic treatment [4].
Consequently, such a general conclusion proposed by the
authors stating that C. albicans serotype B is more sensitive
to photoinactivation is not supported by the evidence, as it
requires studies concerning different sensitizing agents.
However, the authors have not provided any details about
the effectiveness of photoinactivation against both
C. albicans serotypes based on other photosensitizers.
Assessing the influence of microorganism’s features on
susceptibility to photoinactivation is always a complex issue.
Of course, studying one sensitizer and single isolates can
give us some information, but the problems in study design
should not be ignored, as statistical analysis requires more
numerous groups to be compared and to draw relevant con-
clusions. Those limitations reduce the reliability of presented
results.
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